At the news
? BULLISHIMPACT 6/10 PRESS-RELEASE filed Nov 9, 2026 at 07:02 ET
Kamada reported Q3 2026 revenue of $52.0M (+11% YoY) and EPS of $0.14, beating the $0.13 consensus. The company raised its full-year 2026 guidance to $205M-$208M revenue and $52M-$54M adjusted EBITDA, citing strong demand for KEDRAB and other plasma-derived products.
- Q3 2026 revenue $52.0M, up 11% YoY from $47.0M
- Q3 2026 GAAP diluted EPS $0.14, up 56% from $0.09 YoY
- Q3 2026 adjusted EBITDA $15.2M, up 30% YoY, margin 29%
- Q3 2026 net income $8.0M, up 51% YoY
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access